In Silico Evaluation of the Potential Antiarrhythmic Effect of Epigallocatechin-3-Gallate on Cardiac Channelopathies

Figure 4

Repolarization dispersion across the ventricular wall. (a) Superimposition of the epi-, midmyo-, and endocardial action potentials (TNNP cells models) in absence of E3G. (b) Superimposition of the epi-, midmyo-, and endocardial action potentials in the presence of 30 μM E3G.

(a) Epi-, midmyo-, and endocardial cell models

(b) Epi-, midmyo-, endocardial cell models